INSURANCE EVIDENCE GUIDE · 10 CURRENT KAISER FILES + 1 ARCHIVED CRITERIA FILE · LAST VERIFIED SEPTEMBER 2026
Disclosure: Some links on this page are affiliate links, marked "sponsored." If you use one, we may earn a fee at no extra cost to you. It does not change what Kaiser's documents say or the order we list your options. We are not affiliated with Kaiser Permanente, and Kaiser does not pay us.
Does Kaiser Cover Ozempic? 2026 Rules, Costs, and What to Ask
Does Kaiser cover Ozempic? Ozempic appears in all 10 current Kaiser plan files we verified, mainly for type 2 diabetes. But the rules are not the same everywhere. California commercial files list it at Tier 2 with no plan-level prior authorization or step therapy. Colorado, Georgia, Washington, and the Northwest add limits or approval rules. For weight loss alone, don't count on it.
One more thing before you call Kaiser. Kaiser Northwest rewrote its Ozempic rules on July 1, 2026 — and the older November 2025 PDF is still online. We put the old and current rules side by side below, so you don't prepare for the wrong test.
This page is for you if:
- You have Kaiser and want to know if it will pay for Ozempic
- You have a Kaiser appointment coming and want to walk in ready
- The pharmacy or your doctor said no, and you don't know why
This page is not for you if:
- You want dosing or side-effect advice (that's your clinician's call — see our Ozempic dosage chart)
- You want us to promise what your plan pays. Only Kaiser can do that — but we'll show you how to get that answer in one call.
- You're shopping for compounded semaglutide. We found no compounded semaglutide coverage in the Kaiser files we reviewed, and we keep compounded drugs separate from FDA-approved Ozempic.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
The 30-second answer
| Your reason for Ozempic | What the files show | What decides your answer |
|---|---|---|
| Type 2 diabetes | Ozempic is listed in all 10 current Kaiser files we checked | Your exact plan, covered use, regional rules, records, and prescriber |
| Type 2 diabetes + heart or kidney disease | Kaiser Northwest has separate criteria lanes with fewer medicine steps than its standard adult lane | Your diagnosis, records, and the rule for your region |
| Weight loss, no diabetes | Don't count on Ozempic coverage | Whether your plan covers weight-loss drugs and which FDA-approved option fits |
| Kaiser Medicare | Regular Part D may cover Ozempic for an FDA-approved use; the $50 Medicare GLP-1 Bridge does not include Ozempic | Your current formulary, tier, prior authorization, and Evidence of Coverage |
| Medi-Cal (California Medicaid) | Weight-loss GLP-1 coverage ended January 1, 2026; non-weight-loss uses such as type 2 diabetes can still be covered | Medi-Cal Rx rules, not Kaiser's commercial formulary |
### Check my Kaiser Ozempic rules → Pick your region, your plan type, and your reason. See the closest public Kaiser rule, the date it took effect, and what's still missing. 30 seconds. No email. No health records.
What we actually verified
We opened the documents ourselves and wrote down only what they say.
| What we checked | Date checked |
|---|---|
| 10 current Kaiser commercial or Marketplace files across California, Colorado, Georgia, Hawaii, Washington, and the Northwest | September 22, 2026 |
| Kaiser Northwest Ozempic criteria — the current version effective July 1, 2026 and the older version effective November 6, 2025 | September 22, 2026 |
| Kaiser's 2026 Medicare formulary page, its next formulary file effective October 1, 2026, and Medicare's GLP-1 Bridge list | September 22, 2026 |
| Medi-Cal Rx's January 1, 2026 GLP-1 coverage change and hearing rules | September 22, 2026 |
| Novo Nordisk's Ozempic and Wegovy self-pay prices and savings-card terms | September 22, 2026 |
| Ro and Sesame published program prices and what each service says it provides | September 22, 2026 |
What we could not verify: your exact plan, your copay, whether your Kaiser pharmacy processes the Ozempic savings card, and any Kaiser approval rate. Kaiser doesn't publish one. If a website shows you a Kaiser "approval percentage," ask where it came from.
Three common claims the primary documents do not support
| Common claim | What the current documents actually show |
|---|---|
| "Kaiser uses one national Ozempic rule." | No. The 10 current files we checked use different tiers and restrictions by region and plan. |
| "Every Kaiser plan requires prior authorization for Ozempic." | No. The current California commercial and Marketplace files we checked say Kaiser Foundation Health Plan has no plan-level PA or step-therapy requirement. Colorado, Georgia, Washington, and the Northwest use restrictions in the current files reviewed. Kaiser's next posted Medicare formulary, effective October 1, also lists prior authorization. |
| "Medicare's $50 GLP-1 Bridge covers Ozempic." | No. The current Bridge list names Foundayo, Wegovy, and Zepbound KwikPen — not Ozempic. |
Does Kaiser cover Ozempic?
Kaiser lists Ozempic in all 10 current Kaiser files we verified, but that does not mean every Kaiser member is covered. Some plans add prior authorization or other limits; the California commercial files we checked do not. Your Evidence of Coverage, covered use, medical-necessity rules, pharmacy rules, and prescriber still control your personal answer.
Here's the part most pages skip. "Does Kaiser cover it?" is really three questions:
- Is Ozempic on my plan's drug list? It appears in all 10 current public files we checked.
- Does my plan pay for it for my reason? It may for an FDA-approved use when the plan's rules are met. Don't assume it will for weight loss alone.
- Will my Kaiser doctor prescribe it? Kaiser says it plainly in its own formulary: a drug being on the list does not mean that your doctor will prescribe it.
Most frustration comes from mixing those up. Someone hears "Ozempic is on the list," asks for it for weight loss, and gets a no that feels random. It isn't random. It's question 2.
Why every Kaiser region gives a different answer
There is no single "Kaiser formulary." A formulary is a plan's list of covered drugs. Kaiser runs separate lists by region and plan type — and they don't treat Ozempic the same way.
The Kaiser Ozempic Evidence Matrix — verified September 22, 2026
| Kaiser region and public file | Ozempic tier or status | Extra rules shown in the file | What this tells you | Primary source |
|---|---|---|---|---|
| Northern California Commercial HMO (effective Sept. 1, 2026) | Tier 2 | No plan-level PA or step therapy | The public file does not add those two gates. Medical necessity, your EOC, the prescriber, and pharmacy rules still matter. | Kaiser Northern California formulary |
| Southern California Commercial HMO (effective Sept. 1, 2026) | Tier 2 | No plan-level PA or step therapy | Same public California commercial rule; your exact benefit still controls. | Kaiser Southern California formulary |
| California Marketplace (2026) | Tier 2 | No plan-level PA or step therapy | Your Evidence of Coverage sets the benefit and cost. | Kaiser California Marketplace formulary |
| Colorado Commercial HMO (revised Sept. 15, 2026) | Tier 3 | PA, day-supply limit | Expect plan review before the claim is paid. | Kaiser Colorado HMO formulary |
| Colorado Marketplace (revised Sept. 15, 2026) | Tier 3 | PA, day-supply limit | Same public tier and restriction codes as the Colorado HMO file. | Kaiser Colorado Marketplace formulary |
| Georgia Four-Tier plan (current Sept. 9, 2026) | Tier 4 for the listed 0.25/0.5 mg starter pen row | PA, quantity limit | The starter-strength row is on the highest tier in this four-tier file. | Kaiser Georgia Four-Tier formulary |
| Georgia Five-Tier plan (current Sept. 9, 2026) | Tier 5 specialty for the listed 0.25/0.5 mg starter pen row | PA, quantity limit | The starter-strength row is in the specialty tier in this file. | Kaiser Georgia Five-Tier formulary |
| Hawaii Marketplace (effective May 1, 2026) | Tier 3 | No restriction code printed beside the Ozempic pen rows | Ozempic is listed, but the EOC and plan rules still decide personal coverage. | Kaiser Hawaii Marketplace formulary |
| Washington individual and small group (September 2026 public file) | Tier 2 | PA, quantity limit | The same file says most plans exclude drugs used for weight loss. | Kaiser Washington formulary |
| Northwest (Oregon and southwest Washington; criteria effective July 1, 2026) | Formulary | Quantity limit and detailed criteria | This is the most detailed public Ozempic rule set we found. | Kaiser Northwest Ozempic criteria |
Read this before you use the table:
- Tier numbers don't compare across regions. Tier 2 in California and Tier 2 in Washington are different plans with different benefit designs and prices.
- Codes, in plain words: PA (prior authorization) = the plan must approve before it pays. Step therapy = the plan may require other drugs first. Quantity limit (QL) = a cap on how much you get per fill. Day-supply limit (DS) = a cap on how many days one fill can cover.
- Kaiser updates formularies during the year. The California and Medicare pages say their files are updated regularly, including monthly formulary updates. Check the effective or revision date on yours.
- This table cannot tell you whether Kaiser will approve Ozempic for you or what you will pay. It can stop you from following the wrong region's rule.
The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
For the full region-by-region picture across every GLP-1, see what GLP-1 Kaiser covers. This page stays on Ozempic.
Does Kaiser cover Ozempic for type 2 diabetes?
Ozempic is listed in every current Kaiser file we checked, mainly under diabetes coverage, but the public files do not promise approval for every member with type 2 diabetes. California commercial files show Tier 2 with no plan-level PA or step therapy. Northwest publishes specific medicine-history and A1c rules.
So the real question for members with diabetes isn't only if. It's which Kaiser file controls your plan and what that file wants to see first.
California commercial files: no plan-level PA or step therapy
Kaiser's current Northern and Southern California commercial formularies say Kaiser Foundation Health Plan does not require prior authorization or step therapy at the plan level. Ozempic is listed at Tier 2 in both files.
That's good news. It also moves the decision. You do not have a plan-level PA or step-therapy gate in those public files. Your Kaiser prescriber, medical necessity, your Evidence of Coverage, and the Kaiser or affiliated pharmacy rule still matter.
What that means for you: bring your records and your questions. Do not prepare for another region's drug ladder unless your own plan document tells you to.
Northwest: the July 1, 2026 rewrite
Kaiser Northwest publishes its Ozempic rules as a public PDF. On July 1, 2026, a new version took effect (revised June 11, 2026). The older version, effective November 6, 2025, is still online at a different web address. If you searched and found a PDF, check the "Effective" date at the top.
We put the old and current rules side by side.
| Kaiser Northwest Ozempic rule | Old version — effective Nov. 6, 2025 | Current version — effective July 1, 2026 |
|---|---|---|
| Standard adult diabetes steps, not on insulin or on lower-dose insulin | Metformin, a sulfonylurea, pioglitazone, an SGLT2 drug, and liraglutide — each taken, or a documented reason the member could not take it | At least 2 of 4: metformin, a sulfonylurea such as glipizide, pioglitazone, or an SGLT2 drug for 3 or more months — or a documented reason the remaining drugs cannot be used — plus liraglutide up to 1.8 mg or a documented reason it cannot be used |
| A1c or GMI rule | Above the member's goal, but no more than 2 percentage points above it | Above 6.9% and below 10% after the required trials |
| Higher-dose insulin, 0.5 units/kg/day or more | Metformin + an SGLT2 drug or pioglitazone + liraglutide | Metformin + liraglutide, with A1c or GMI above 6.9% |
| Type 2 diabetes + clinical heart or artery disease | Separate lane | Separate lane; metformin plus a documented reason SGLT2 drugs and liraglutide cannot be used |
| Type 2 diabetes + proteinuria | Separate lane | Separate lane with urine-protein, kidney-function, ACE/ARB, SGLT2, and liraglutide criteria |
| Members age 12–19 with type 2 diabetes | Yes | Yes — A1c or GMI above 6.9% and below 10% unless the member is on insulin |
| Weight management, teen obesity, cardiovascular risk without diabetes, sleep apnea, and MASH | Listed as Ozempic criteria lanes in the old file, with benefit limits | Absent from the current Ozempic criteria file |
The two source files are Kaiser's current Northwest criteria and the older November 2025 criteria.
Two plain takeaways:
- The standard diabetes ladder got shorter. You no longer need all five listed drugs. The current standard adult lane asks for two of the first four, plus liraglutide, or documented reasons the other drugs cannot be used.
- The old non-diabetes lanes are gone from the current Ozempic criteria. That fact does not tell you which other drug or benefit now applies. Ask which current rule controls your situation.
Words that matter in these rules:
- "Adequate trial" = 3 months on the drug.
- "Intolerance" does not include side effects that are expected, mild, go away with continued treatment, and do not make you stop the medicine.
Please don't keep taking a medicine just to meet a rule. If a side effect is bad or won't quit, call your doctor — and ask them to write down exactly what happened.
The shorter Northwest lists: heart disease or kidney damage
If you have type 2 diabetes and clinical heart or artery disease, Northwest's list is shorter. Kaiser defines this as conditions such as a past heart attack, stroke, TIA, stents or bypass, angina, or symptomatic artery disease in the legs. The lane asks for metformin, or a reason you cannot take it, and a documented reason you cannot take an SGLT2 drug or liraglutide.
The kidney lane is for type 2 diabetes with protein in the urine. It calls for at least two urine tests with an albumin-to-creatinine ratio over 300 mg/g or a protein-to-creatinine ratio over 0.5, an eGFR of at least 30, an ACE inhibitor or ARB unless it cannot be used, and allergy or intolerance to both an SGLT2 drug and liraglutide.
The current FDA-approved uses for Ozempic injection include lowering certain heart risks in adults with type 2 diabetes and known heart disease, and lowering certain kidney and cardiovascular risks in adults with type 2 diabetes and chronic kidney disease. Those are FDA-approved uses; the Kaiser criteria still decide the plan path. See Ozempic's current official uses.
Already on Ozempic and new to Kaiser Northwest?
Good news if you switched jobs. Northwest has a separate "already taking it" lane. For adults with type 2 diabetes who are not on high-dose insulin, it asks for a current or past history of at least 2 of the 4 listed diabetes drug groups and an A1c or GMI below 10%. The current file does not show a liraglutide step in that transition lane. Bring your pharmacy history and your last A1c to your first visit.
"What if my A1c is 10% or higher?"
Northwest's standard adult lane only fits an A1c or GMI above 6.9% and below 10%. If yours is 10% or higher, that lane does not fit. Ask your doctor which published lane, if any, applies to your situation.
Bring this to your Kaiser visit
- [ ] Your Kaiser region and plan type, shown on your card or kp.org
- [ ] Your latest A1c and the date
- [ ] Every diabetes medicine you've taken: name, dose, start and stop dates, and why you stopped
- [ ] Any heart, artery, or kidney history, only if true
- [ ] Any personal or family history of medullary thyroid cancer or MEN 2, if true and your prescriber asks; Kaiser's Northwest criteria and Ozempic's label screen for these
- [ ] Any denial letter or pharmacy message
Message for your Kaiser doctor — copy and send through kp.org:
"Hi Dr. [Name] — I'd like to talk about Ozempic for my type 2 diabetes. My last A1c was [X] on [date]. I've taken [medicines, doses, and dates]. Can we check which Kaiser Ozempic criteria apply to my plan, and what's still missing before we ask?"
### Copy this message for my Kaiser doctor One tap. No sign-up. Your doctor gets the exact facts the public Kaiser rules ask about.
Honest note: If Kaiser approves Ozempic and your signed-in price is lower than cash, stay inside Kaiser. Check that number before you pay an outside program.
Does Kaiser cover Ozempic for weight loss?
Usually no for weight loss alone. Ozempic is an FDA-approved type 2 diabetes medicine, not a weight-loss drug, and several Kaiser files say weight-loss drugs are excluded or depend on a separate benefit. Northwest's current Ozempic criteria contain only diabetes lanes. If your plan covers weight-loss medicine, ask which FDA-approved option fits your plan and medical needs.
We know that's not the answer you wanted. Stay with us, because there's a better question to ask.
Why the answer is "no" so often
Two separate walls:
- The label. Ozempic is not an FDA-approved weight-loss drug. Wegovy is a separate semaglutide product with FDA-approved weight-management uses.
- The benefit. Many plans simply don't buy weight-loss drug coverage. Kaiser's Washington file says most of its listed plans exclude drugs for weight loss. Kaiser's Colorado formulary says drugs used for weight loss are usually not covered and tells members to check their Evidence of Coverage.
The second wall is the one people waste months on. A doctor's letter can't create a benefit your plan never bought.
Check your weight-loss benefit in 5 minutes
- Sign in at kp.org and open your Evidence of Coverage, or EOC — your plan's contract. Search for "weight loss," "obesity," and "anti-obesity."
- Got Kaiser through work? Ask HR this exact question: "Does our Kaiser plan cover weight-loss medicines — not diabetes drugs, but FDA-approved weight-loss drugs such as Wegovy?" Say it that way, or you may hear "yes, we cover GLP-1s" when they mean diabetes only.
- Call Member Services using the number on your card. Write down the rep's name, the date, and a reference number if one is offered.
The smarter ask may be Wegovy, not Ozempic
If you don't have diabetes and your plan does cover weight-loss drugs, ask your Kaiser doctor which FDA-approved weight-management option fits you. Wegovy is one option. Here are the current facts people often mix together:
| Current fact | Ozempic | Wegovy |
|---|---|---|
| FDA-approved for chronic weight management? | No | Yes, for people who meet its labeled criteria |
| In Medicare's $50 GLP-1 Bridge? | No | Yes, injection or tablet, for eligible members |
| NovoCare price for the first two low-dose pen fills for eligible new self-pay patients through Dec. 31, 2026 | $199/month at 0.25 or 0.5 mg | $199/month at 0.25 or 0.5 mg |
| Standard NovoCare pen price after the intro offer | $349/month at 0.25, 0.5, or 1 mg; $499/month at 2 mg | $349/month through 2.4 mg; $399/month for Wegovy HD 7.2 mg |
| NovoCare tablet price | $149/month at 1.5 mg; $199 at 4 mg; $299 at 9 mg | $149/month at 1.5 mg; $199 at 4 mg; $299 at 9 or 25 mg |
Prices are manufacturer self-pay prices checked September 22, 2026. Eligibility and terms apply. Ozempic and Wegovy are separate FDA-approved products, and the doses in this table are not dose-equivalent. See current Ozempic prices and current Wegovy prices.
Read the pen-price row again. At current NovoCare self-pay prices, the Ozempic 2 mg pen costs $150 more per month than the Wegovy 2.4 mg pen. Those are different products and doses, not a dose-for-dose switch. For weight management, ask about the product approved and covered for your situation.
→ Next: Does Kaiser cover Wegovy?
Please don't change your diagnosis to fit a rule
Every path on this page is for conditions you actually have. Asking a doctor to list a diagnosis you don't have can get your coverage pulled and cause bigger problems later. The honest path is also the one that lasts.
If your plan says no to weight-loss drugs
This is where an outside program can make sense — and only here.
Ro cannot change a Kaiser benefit exclusion, and an outside prescription may not use Kaiser's pharmacy benefit. If using Kaiser coverage is your priority, your Kaiser doctor is the better path — go back to the diabetes section or the Wegovy guide. But if your plan excludes weight-loss drugs and you choose to pay cash, Ro offers a separate path to FDA-approved weight-management treatment.
What Ro says it offers:
- A licensed clinician who can prescribe FDA-approved options such as Wegovy, Zepbound, or Foundayo when medically appropriate
- Membership: $39 for the first month, then as low as $74/month with an annual plan paid upfront — or $149/month if you stay month to month. Medication is billed separately.
- An insurance concierge that can check coverage and handle prior-authorization paperwork for supported drugs, but it cannot force Kaiser to cover an excluded benefit
Skip Ro if Kaiser already covers the right treatment for you at a lower total price.
### Plan excludes weight-loss drugs? See if an FDA-approved cash-pay option on Ro fits → (sponsored link) Get started for $39, then as low as $74/month with an annual plan paid upfront. Medication is extra. See Ro's current pricing and read our full Ro review first if you like.
How much does Ozempic cost with Kaiser?
There is no single Kaiser price for Ozempic. Your cost depends on your plan's tier, deductible, copay or coinsurance, pharmacy, and whether the claim is approved. Your Evidence of Coverage controls it. Without coverage, Novo Nordisk's current self-pay prices range from $149 a month for the lowest Ozempic tablet dose to $499 a month for the 2 mg pen.
You'll see websites quote a "typical Kaiser copay." We checked. No Kaiser document supports one national number, and Kaiser's own formulary says the formulary does not provide each member's exact copay or coinsurance.
Get your real number in 3 minutes
- Sign in at kp.org or the Kaiser app.
- Go to Benefits, then under Plan for your care, choose Drug cost.
- Search "Ozempic." Pick the exact form, dose, supply, and pharmacy.
Then ask Member Services:
"Is Ozempic covered on my plan for the reason it was prescribed? What tier is it? Do I have a deductible first? What's my copay or coinsurance at a Kaiser pharmacy and by mail? Are there any prior-authorization, quantity, or day-supply rules?"
### Check my exact Kaiser drug cost Opens Kaiser's own sign-in page. We don't see your information.
Every current payment path, side by side
| Payment path | Current amount or rule | Who it may fit |
|---|---|---|
| Kaiser coverage | Your plan's tier cost share after any deductible, subject to approval and pharmacy rules | Kaiser members whose use and claim meet the plan rules |
| Kaiser commercial coverage + Ozempic Savings Card | Eligible commercially insured patients with Ozempic coverage may pay as little as $25, with up to $100 off per month | Ask the Kaiser pharmacy first whether it can process the card; the offer is not guaranteed |
| Kaiser Medicare Part D | Your plan's cost share. The 2026 Part D annual out-of-pocket threshold is $2,100 for covered Part D drugs. Manufacturer savings cards cannot be used. | Medicare members using the regular Part D benefit |
| NovoCare self-pay — Ozempic pen | $199/month for the first two 0.25 or 0.5 mg fills for eligible new patients through Dec. 31, 2026; then $349 at 0.25, 0.5, or 1 mg and $499 at 2 mg | A patient with a prescription who pays outside insurance and meets the offer terms |
| NovoCare self-pay — Ozempic tablet | $149/month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg | A patient with a prescription who pays outside insurance and meets the offer terms |
| Costco Member Prescription Program | Current Ozempic promotion: $199/month for the first two 0.25 or 0.5 mg fills for eligible new patients, then $349 at up to 1 mg and $499 at 2 mg | Costco members with a valid prescription who use the self-pay offer outside insurance |
The manufacturer terms and pharmacy processing control the final amount. See Ozempic's current savings terms, the 2026 Medicare Part D threshold, and Costco's current member prices.
Savings-card math, in plain numbers: the card can lower an eligible covered share by up to $100 a month, but not below $25. If your covered share is $140 and the full $100 applies, you would pay about $40. If your covered share is $60, the card could lower it to $25 — not $0. Ask the pharmacy to run it before you count on the result.
A lower membership option for Costco members
If you're paying cash anyway, need a separate prescriber, and shop at Costco, Sesame is worth a look. Success by Sesame starts at $59/month with an annual subscription. Medication is separate. The program says it includes video visits, labs, messaging, and ongoing care from a provider the patient chooses.
Sesame does not replace your Kaiser benefit either. It may fit if Kaiser will not cover your use, you want a separate clinician, and the total subscription plus medication cost works for you. Costco's drug discount itself still requires an active Costco membership and a valid prescription.
### Need a separate prescriber and use Costco? See Sesame's current program → (sponsored link) Plans start at $59/month with an annual subscription; medication is extra. See Sesame's current program terms and read our Sesame review.
Does Kaiser Medicare, Medi-Cal, or a federal plan cover Ozempic?
Kaiser Medicare may cover Ozempic under regular Part D for an FDA-approved use when the current formulary and plan rules are met. Ozempic is not in Medicare's $50 GLP-1 Bridge. Medi-Cal continues GLP-1 coverage for non-weight-loss uses such as type 2 diabetes, but ended weight-loss GLP-1 coverage on January 1, 2026. FEHB and PSHB members must use their exact 2026 brochure.
Kaiser Medicare, or Senior Advantage
- Regular Part D: Do not assume a national yes. Check the current formulary and EOC for your exact Kaiser Medicare plan and region.
- The next posted Kaiser Medicare formulary: A Kaiser comprehensive formulary posted for October 1, 2026 lists Ozempic pens at Tier 3 with prior authorization and mail-order availability. Because that file is future-effective on this page's September 22 verification date, do not use it as today's personal answer. See Kaiser's 2026 Medicare formulary page.
- The $50 Bridge is not for Ozempic. The current Medicare GLP-1 Bridge names Foundayo tablets, Wegovy injection or tablets, and Zepbound KwikPen. Ozempic is not listed.
- People with type 2 diabetes are not eligible for the Bridge on that basis. Medicare says the regular Part D plan may cover a GLP-1 for that condition.
- Bridge cost: eligible members pay $50 for a 28- or 30-day supply. That payment does not count toward the regular Part D deductible or out-of-pocket limit and cannot be lowered by Extra Help or spread through the Medicare Prescription Payment Plan.
- Savings cards do not work with Medicare.
If you're on Medicare and want treatment for weight, use Medicare's current eligibility questions before asking about the Bridge. Here's how Kaiser and the Bridge work together. See Medicare's current Bridge rules.
Medi-Cal through Kaiser
In California, Medi-Cal Rx runs the pharmacy benefit for Medi-Cal members.
- Since January 1, 2026, Medi-Cal Rx no longer covers GLP-1 drugs when they are used for weight loss, with a limited under-21 exception tied to federal EPSDT rules.
- Medi-Cal Rx continues GLP-1 coverage for other, non-weight-loss uses such as type 2 diabetes. The exact drug list and prior-authorization rules still apply.
- If you receive a Notice of Action denying GLP-1 coverage, you generally have 90 days from the notice date to ask for a State Hearing.
- A narrower 10-day continued-treatment window may apply if you were already taking a GLP-1 on or before January 1, 2026 and the notice denies continued coverage. Follow the dates and conditions printed on your notice.
More: what GLP-1 Medicaid covers. See Medi-Cal Rx's current notice.
Federal and postal employees, FEHB and PSHB
Your OPM plan brochure controls. Do not use a generic Kaiser tier or coinsurance from another federal or postal plan. Search the exact 2026 brochure for Ozempic, semaglutide, prior authorization, weight-loss drugs, and anti-obesity drugs, then call the number in that brochure if the result is unclear.
Why did Kaiser deny my Ozempic?
A Kaiser Ozempic denial usually means the use or benefit does not match, prior authorization or another criterion is missing, a regional A1c or medicine-history rule was not met, a quantity or day-supply limit applies, the pharmacy path is wrong, or the claim has an administrative error. The fix depends entirely on the written reason, so get that reason first.
| What the denial says | What it may mean | Your next move |
|---|---|---|
| Diagnosis or covered use does not match | The claim information does not match a covered use, or the plan does not cover that use | Ask for the exact rejection text and the covered-use rule. Do not change a diagnosis that is not true. |
| Prior authorization required | The plan review was not completed or approved | Get the exact criteria and ask the prescriber to answer each item. |
| Step therapy or treatment history not met | A required medicine is missing from the record, or the wrong region's history was submitted | Ask which drug, duration, and current plan file apply. Take nothing only for paperwork; discuss safe options with your clinician. |
| Criteria not met — A1c or GMI | A regional rule uses a range that the submitted result does not fit | Ask which lane applies. In Northwest's standard adult lane, the current range is above 6.9% and below 10%. |
| Quantity or day-supply limit | The requested amount is over the plan cap | Ask whether the prescription can be corrected or whether a limit exception is available. |
| Benefit exclusion | The plan did not include this drug category or use | A medical-necessity letter cannot create the missing benefit. Check a covered FDA-approved alternative, open-enrollment options, or cash-pay treatment. |
| Wrong prescriber or pharmacy path | The plan requires a Kaiser or affiliated prescriber or pharmacy for that claim | Ask exactly who may prescribe and where it must be filled before paying outside Kaiser. |
| Claim-processing error | Member data, product code, timing, refill amount, or another administrative field may be wrong | Ask the pharmacy for the rejection code and have the plan identify the failed field. |
The one difference that saves the most time: a benefit exclusion means your plan never bought that coverage. A medical-necessity denial means the benefit may exist, but the plan says your case does not meet its rule. The second may be fixed with records that answer the rule. The first usually cannot.
If a pharmacy just says "not covered," ask for the exact rejection reason. Our pharmacy rejection code guide decodes the common ones.
Can I appeal a Kaiser Ozempic denial?
Yes. Kaiser members can ask for a coverage decision, a formulary exception, or an appeal when the plan allows it, and the right process depends on the plan type and denial reason. An appeal can fix missing records or challenge a medical-necessity decision, but it usually cannot create a benefit the plan contract excludes.
Before you file, gather:
- The full denial letter, including the exact reason and deadline
- The Kaiser rule that applies to your plan, including its name and effective date
- Your records: A1c results, medicine history with dates, and any documented reason a required drug cannot be used
- A short note from your doctor answering the exact reason for the denial
- The Evidence of Coverage language if the dispute is about an exclusion or pharmacy rule
How fast Kaiser decides depends on the request and plan. Kaiser's California commercial formulary says a standard coverage decision is made within 72 hours and an urgent one within 24 hours after the needed prescriber statement. Kaiser Medicare uses the same 72-hour and 24-hour time frames for the coverage-decision and exception process described on its Medicare page. Those are not universal deadlines for every later appeal in every Kaiser plan. Follow your denial letter.
Where to go next, by plan:
| Your plan | First step | If Kaiser still says no |
|---|---|---|
| Job or self-bought plan | Kaiser coverage decision, grievance, or appeal named in the notice | Your state's external-review process. In California, a qualifying DMHC Independent Medical Review is free, uses independent doctors, and a decision in your favor requires the plan to cover the approved service or treatment. |
| Medicare | Coverage determination or exception, then plan redetermination | The later Medicare appeal levels listed in the denial notice |
| Medi-Cal | State Hearing | Watch the 90-day deadline and any narrower 10-day continued-treatment rule printed on the notice |
| Federal or postal plan | Plan appeal under the brochure | OPM review when the brochure allows it |
### Build my appeal-prep checklist Pick your denial reason and plan type. Get the documents to gather and the deadline to watch. Then use our free GLP-1 appeal letter template — no email required.
For California commercial review rules, see the current Kaiser formulary and DMHC's Independent Medical Review guidance.
What if Kaiser won't cover Ozempic and I still want to start?
Go in this order: a Kaiser path you truly qualify for, then Medicare's $50 Bridge for an eligible weight-management drug if you're on Medicare and meet its rules, then the manufacturer's own cash prices, then a telehealth program. The first three don't pay us anything — and for many readers, they're the cheapest.
- Kaiser, for the right reason. Type 2 diabetes? Use the checklist above. Weight? Ask which FDA-approved weight-management drug your benefit covers.
- Medicare's $50 Bridge — Foundayo, Wegovy, or Zepbound KwikPen, only if you meet Medicare's current eligibility rules. Type 2 diabetes itself sends the claim back to regular Part D, not the Bridge.
- Open enrollment. If your job offers more than one plan, compare the drug list and the weight-loss benefit before the new plan year.
- Cash, direct from Novo Nordisk — Ozempic pen from $199 for the limited low-dose intro offer, then $349–$499 by dose; Ozempic tablets from $149–$299. You need a valid prescription and must meet the offer terms.
- A telehealth program such as Ro or Sesame — if you want a separate prescriber and ongoing support outside Kaiser and understand the full membership plus medication cost.
What about compounded semaglutide? We found no compounded semaglutide coverage in the Kaiser files we reviewed. Compounded drugs are not FDA-approved, the FDA does not review them for safety, effectiveness, or quality before marketing, and they are not Ozempic or Wegovy. We keep them separate. If you're weighing that choice, read compounded vs. name-brand GLP-1s first. See the FDA's compounding explanation.
Can an outside doctor prescribe Ozempic and use my Kaiser coverage?
Do not pay for an outside visit until Kaiser answers this. Kaiser's California commercial formulary says listed drugs are covered when they meet the plan rules and are filled at a Kaiser or affiliated pharmacy. Kaiser Medicare also generally requires a Kaiser or affiliated prescriber and pharmacy. Other Kaiser products can differ.
Ask Kaiser first:
"Can an outside prescriber use my Kaiser pharmacy benefit for Ozempic, and where would it need to be filled?"
An outside prescription may work for cash even when it does not work through your Kaiser benefit.
More: GLP-1 providers that work with Kaiser members.
How we built this page
We read Kaiser's own documents, dated each one, and wrote down only what they say. Where a document couldn't answer a question — like your exact copay — we say so instead of guessing.
- What we opened: 10 current Kaiser commercial or Marketplace files covering Northern and Southern California, California Marketplace, Colorado HMO and Marketplace, Georgia Four-Tier and Five-Tier, Hawaii Marketplace, Washington individual and small group, and Northwest Ozempic criteria; the archived November 2025 Northwest criteria; Kaiser's Medicare formulary page and posted October 1 file; Medicare's GLP-1 Bridge page; Medi-Cal Rx notices; and current NovoCare, Ro, Sesame, and Costco price pages.
- How we compared them: we searched each Kaiser file for "Ozempic" and "semaglutide," recorded the tier and restriction codes, and wrote down effective or revision dates. Future-effective files are labeled as future.
- What we won't publish: a Kaiser approval rate, a national Kaiser copay, or a Kaiser rule from one region presented as national.
- Testimonials: we don't post patient stories on insurance pages. Someone else's result can't tell you what your plan covers.
- Review: no clinician reviewed this insurance-document guide, and we won't pretend one did. It is not medical advice. Treatment decisions belong to you and your clinician. See our methodology.
Change log: September 22, 2026 — first published. Compared the Northwest July 1, 2026 rewrite with the still-online November 2025 file; verified 10 current regional Kaiser files; checked current Medicare, Medi-Cal, manufacturer, Ro, Sesame, and Costco terms.
Frequently asked questions
Does Kaiser cover Ozempic for weight loss?
Usually no for weight loss alone. Ozempic is not an FDA-approved weight-loss drug, and several Kaiser files exclude weight-loss drugs or make them depend on a separate benefit. Kaiser Northwest's current Ozempic criteria contain only diabetes lanes. If your plan covers weight-loss medicine, ask which FDA-approved product and plan rule apply.
Will a Kaiser doctor prescribe Ozempic if I don't have diabetes?
A formulary listing does not force a Kaiser doctor to prescribe Ozempic. Without type 2 diabetes or another current FDA-approved Ozempic use, expect the doctor to discuss a different treatment path. Coverage and prescribing are separate decisions.
Does Kaiser require prior authorization for Ozempic?
It depends on your region and plan. The current California commercial and Marketplace files we checked say Kaiser Foundation Health Plan has no plan-level prior-authorization requirement. Colorado, Georgia, Washington, and Northwest use prior authorization or detailed criteria. Kaiser's next posted Medicare formulary, effective October 1, also lists prior authorization.
How many drugs do I have to try before Kaiser Northwest covers Ozempic?
Under the standard adult rules effective July 1, 2026, the member must be taking at least 2 of metformin, a sulfonylurea, pioglitazone, or an SGLT2 drug for at least 3 months, or have documented reasons the remaining drugs cannot be used, plus liraglutide or a documented reason it cannot be used. Heart, kidney, insulin, teen, and transition lanes use different rules.
What A1c does Kaiser need for Ozempic?
In Kaiser Northwest's standard adult lane, A1c or GMI must be above 6.9% and below 10% after the listed treatment trials. Other regions do not publish that same rule in the files we checked, so ask which criteria apply to your plan.
What tier is Ozempic on Kaiser?
It varies. The current public examples we verified include Tier 2 in California and Washington, Tier 3 in Colorado and Hawaii, and Tier 4 or Tier 5 for the listed starter-strength row in the Georgia files. The same tier number can cost different amounts on different plans.
How much is Ozempic with Kaiser insurance?
Only your plan can say. Use kp.org → Benefits → Plan for your care → Drug cost, then choose the exact Ozempic form, dose, supply, and pharmacy. Without coverage, the current manufacturer self-pay price ranges from $149 to $299 for the tablets and from a limited $199 low-dose pen intro offer to $499 for the 2 mg pen.
Can I use the Ozempic savings card with Kaiser?
Only eligible patients with commercial coverage for Ozempic can use the current manufacturer card, and the pharmacy must be able to process it. It can lower the covered share to as little as $25, with up to $100 off per month. Medicare, Medicaid, and other government-benefit members are excluded. Ask your Kaiser pharmacy before you fill.
Does Kaiser cover the Ozempic pill?
Do not assume it. The regional commercial files we verified clearly list the Ozempic pens, but they do not give us enough current evidence to promise tablet coverage across Kaiser. Search your exact formulary for Ozempic tablet and the exact strength, then confirm it in the signed-in drug-cost tool.
Is Ozempic in Medicare's $50 GLP-1 Bridge?
No. The current Bridge covers Foundayo tablets, Wegovy injection or tablets, and Zepbound KwikPen for eligible members. Ozempic may still be considered under a member's regular Part D benefit for an FDA-approved use.
Does Medi-Cal through Kaiser still cover Ozempic?
Medi-Cal Rx stopped covering GLP-1 drugs for weight-loss uses on January 1, 2026. It continues GLP-1 coverage for other, non-weight-loss uses such as type 2 diabetes, subject to the current drug list and rules.
Does Kaiser cover Ozempic for prediabetes or PCOS?
We did not find prediabetes or PCOS as stand-alone covered lanes in Kaiser's current Northwest Ozempic criteria, and neither condition is an FDA-approved Ozempic use. Another Kaiser plan may use different rules, so check the plan document and ask the prescriber what treatment is appropriate.
Is Ozempic the same as Wegovy?
No. Both contain semaglutide and are made by Novo Nordisk, but they are separate FDA-approved products with different doses, uses, and insurance rules. A Wegovy approval does not carry over to Ozempic, or the other way around.
Does Kaiser cover compounded semaglutide?
We found no compounded semaglutide coverage in the Kaiser files we reviewed. Compounded drugs are not FDA-approved and are not the same as Ozempic. Check your EOC before treating that finding as a promise about every Kaiser plan.
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.
Related Kaiser guides
What GLP-1 Does Kaiser Cover? · Does Kaiser Cover Wegovy? · Does Kaiser Cover Mounjaro? · Does Kaiser Cover Zepbound? · GLP-1 Providers That Accept Kaiser · Kaiser and the $50 Medicare Bridge · Does Insurance Cover Ozempic?
Sources
Kaiser Permanente
- Kaiser Northwest, Criteria for Drug Coverage: Semaglutide injectable (Ozempic), revised June 11, 2026, effective July 1, 2026
- Kaiser Northwest, older Criteria for Drug Coverage: Injectable semaglutide (Ozempic), revised Sept. 11, 2025, effective Nov. 6, 2025
- Kaiser Northern California, 2026 Commercial HMO Formulary
- Kaiser Southern California, 2026 Commercial HMO Formulary
- Kaiser California, 2026 Marketplace Formulary
- Kaiser Colorado, 2026 Commercial HMO Formulary
- Kaiser Colorado, 2026 Marketplace Formulary
- Kaiser Georgia, 2026 Four-Tier Benefit Formulary
- Kaiser Georgia, 2026 Five-Tier Benefit Formulary
- Kaiser Hawaii, 2026 Marketplace Formulary
- Kaiser Washington, 2026 Individual and Small Group Formulary
- Kaiser, 2026 Medicare Part D formulary page and drug-cost steps
Government and regulatory
- Medicare, Weight loss drugs — GLP-1 Bridge drugs, eligibility, and $50 copay
- CMS, final 2026 Part D redesign — $2,100 annual out-of-pocket threshold
- Medi-Cal Rx, State Budget Updates — January 1, 2026 GLP-1 coverage change and hearing rights
- California DMHC, Independent Medical Review guidance
- FDA, Compounding and the FDA: Questions and Answers
Official medication and price sources
- Ozempic official uses
- Ozempic official cost, savings-card, and self-pay terms
- NovoCare Wegovy self-pay pricing
- Costco Member Prescription Program
- Ro Body current pricing
- Ro insurance-concierge terms
- Success by Sesame current program and medication offer terms
This page is independent insurance research, not medical advice or a coverage guarantee. Coverage decisions belong to your plan. Treatment decisions belong to you and your clinician. Ozempic® and Wegovy® are trademarks of Novo Nordisk. The RX Index is not affiliated with Kaiser Permanente, Novo Nordisk, Medicare, Medi-Cal, Ro, Sesame, or Costco.
